Skip to main content

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Agency: National Institutes of Health

Assistance Listings
  • 93.CA1 -- National Cancer Institute Research - Research Projects

Open opportunityLast Updated: Nov 3, 2026

Important dates

  • Closing: November 16, 2029

Award details

  • Expected project funding: Not specified
  • Expected awards: Not specified

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:PAR-28-042
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Posted date: November 3, 2026
  • Archive date: January 15, 2030
  • Version: 1

View version history on Grants.gov

The purpose of the Notice of Funding Opportunity (NOFO) is to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, monitoring, prediction of response or resistance to treatment, cancer prevention and control, as well as pharmacodynamic markers and markers of toxicity. Utilizing either a phased UH2/UH3 or a standalone UH3 mechanism, funding will facilitate laboratory optimization and clinical validation of assays that work on human samples and address a clearly defined cancer-related clinical need within a well-specified intended use.

Eligibility

Education

  • Private institutions of higher education
  • Public and state institutions of higher education
  • Independent school districts

Government

  • Federally recognized Native American tribal governments
  • City or township governments
  • State governments
  • Public and Indian housing authorities
  • Special district governments
  • County governments

Business

  • Small businesses
  • For-profit organizations other than small businesses

Nonprofit

  • Nonprofits non-higher education with 501(c)(3)
  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations

Miscellaneous

  • Other

Additional information on eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Documents

File nameDescriptionLast updated
PAR-28-042-Full-Announcement.html
PAR-28-042-Full-Announcement.html
Nov 3, 2026 06:09 PM UTC

Agency contact information

Email: NCICDPNOFO@mail.nih.gov

NCICDPNOFO@mail.nih.gov

Cancer Diagnosis Program NCICDPNOFO@mail.nih.gov

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov